It has long been known that temperature can affect the cornea. In the second part of Dr Farhad Hafezi’s interview, he discusses corneal cross-linking and how this procedure can benefit from reducing the corneal temperature. Recent studies have found that oxygen is a regulator of cross-linking efficacy; reducing the corneal temperature results in increased oxygen diffusion and therefore may yield increased efficacy. Dr Hafezi explains the significance of these early results and highlights how important cross-linking has been in the treatment of corneal diseases. Looking ahead, Dr Hafezi hopes that further studies can confirm the effects of temperature on cross-linking.
1. What role does temperature play in normal corneal physiology and what variations can it cause? (0:09)
2. Can corneal temperature be used as a factor for regulating the efficacy of corneal cross-linking procedures? (0:45)
3. How has corneal cross-linking changed the way that weak corneal integrity is treated in the clinic? (1:49)
4. What further studies on the influence of temperature on corneal function are planned? (2:28)
Speaker disclosure: Farhad Hafezi has no relevant conflicts of interest.
Filmed at the 36th Congress of the European Society of Cataract & Refractive Surgeons (ESCRS), Vienna, Austria, 22–26 September 2018
Share this Video
Related Videos In Corneal Disorders
Jorge L Alió, EGS 2020 – Corneal Regeneration, Will It Be a Reality in 2021?
We were delighted to talk with our Editorial Board member, Jorge L. Alió (Miguel Hernández University of Alicante, Elche, Spain) about the recent technological advances in corneal regeneration. Questions Could you tell us a little about the challenges and opportunities of corneal regeneration? (0:05) What have been the most exciting recent technological advances in corneal […]
Farhad Hafezi, ESCRS 2020 – PACK-CXL Multicentre Trial (Part 2)
It was a pleasure to catch up with our Editorial Board member Prof. Farhad Hafezi (ELZA Institute, Zurich, Switzerland), the winner of the ESCRS 2020 Refractive Award! Here he discusses the PACK-CXL multicentre trial, and the benefits of this treatment. Questions Which patients are likely to benefit most from photoactivated chromophore for keratitis-corneal collagen cross-linking […]
Farhad Hafezi, ESCRS 2020 – PACK-CXL Multicentre Trial (Part 1)
It was a pleasure to catch up with our Editorial Board member Prof. Farhad Hafezi (ELZA Institute, Zurich, Switzerland), the winner of the ESCRS 2020 Refractive Award! Here he discusses the PACK-CXL multicentre trial, and the benefits of this treatment. Questions What are the major challenges in the treatment of infectious keratitis? (00:15) Could you […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!